Men's Health News
New Clinical Guidelines For Egg Freezing In The UK
The British Fertility Society (BFS) and Association of Clinical Embryologists (ACE) have issued new guidelines in the journal Human Fertility on the effectiveness and safety of egg freezing for medical purposes. These guidelines follow a thorough review of published research on different technologies used in egg freezing and present a number of recommendations to UK clinics as follows: -- Egg freezing is an emerging technology with promising initial results.
Categories: Men's Health News
Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomes
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured. The data was presented at the annual meeting of the American Society for Radiation Oncology.
Categories: Men's Health News
In Prostate Cancer Patients Proton Therapy Is Well-Tolerated
Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Categories: Men's Health News
Prostate Cancer Recurrences Reduced By Adding Proton Therapy "Boost" To X-Ray Radiation Therapy
Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Categories: Men's Health News
Short-Term Hormone Therapy And Intermediate Dose Radiation Increases Survivial For Early Stage Prostate Cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the largest randomized trial of its kind, presented November 2, 2009, at the American Society for Radiation Oncology (ASTRO) annual meeting.
Categories: Men's Health News
Disrupting Male Fertility
The sexual function of male rodents can be impaired by in utero and/or neonatal exposure to external molecules that disrupt normal hormone functioning, giving rise to concerns that low-level exposure to such molecules might cause similar effects in humans. Examples of such molecules include the synthetic nonsteroidal estrogen DES, which was used as a treatment for various diseases until the mid 1990s, and BPA, which is found, among other places, in some plastic containers.
Categories: Men's Health News
Short-term Hormone Therapy Added To Radiation Increases Survival For Medium-risk, But Not Low-risk, Prostate Cancer Patients
Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Categories: Men's Health News
Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting.
Categories: Men's Health News
Drug Shows Promise In Treating Dangerous Complication Of Erectile Disorder
Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston. Priapism is a condition of persistent painful penile erection in the absence of sexual desire. It is highly associated with sickle cell disease, leukemia and other blood disorders.
Categories: Men's Health News
One Embryo As Likely To Yield Birth As Two, Study Finds
Women undergoing in vitro fertilization who receive only one embryo are as likely to give birth as women who receive two embryos, according to a study published Wednesday in the New England Journal of Medicine, Reuters/MSNBC reports. The study is a follow-up to a similar 2004 study.
Categories: Men's Health News
Erlotinib Has Moderate Single-agent Activity In Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results Of A Phase II Trial
UroToday.com - This was an open label single institution study that looked at the activity and toxicity of single agent erlotinib in patients with CRPC who have not received chemotherapy yet. The mechanisms by which prostate cancer becomes castration resistant are variable and multiple. One hypothesis is that the overexpression of the epidermal growth factor receptor (EGFR) allows for downstream cell signaling causing cancer cell growth and proliferation.
Categories: Men's Health News
Study Shows How Differing Asian Cultures And Attitudes Impact Cancer Screening Rates
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Health researchers say this makes it difficult to learn about each group's specific needs, particularly in regard to cancer, one of the leading killers of Asian-Americans.
Categories: Men's Health News
Safety And Immunological Efficacy Of A DNA Vaccine Encoding Prostatic Acid Phosphatase In Patients With Stage D0 Prostate Cancer
UroToday.com - In the online edition of the Journal of Clinical Oncology, Dr. Douglas McNeel and associates report a phase I/IIa trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with stage D0 prostate cancer (CaP). PAP is a prostate tumor antigen that can elicit an immunologic antigen-specific CD8+ T cell response. The vaccine, pTVG-HP, is a plasmid DNA encoding the full length human PAP cDNA downstream of a eukaryotic promoter.
Categories: Men's Health News
FDA: Procter & Gamble Unlawfully Marketing Two Vicks Cold And Flu Medicines Containing Vitamin C
The U.S. Food and Drug Administration sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients and a dietary ingredient. Both of the over-the-counter (OTC) medicines, which contain vitamin C in addition to several drug ingredients, are marketed as treatments for cold and flu symptoms.
Categories: Men's Health News
Prostate Cancer-specific Mortality After Radical Prostatectomy For Patients Treated In The Prostate-specific Antigen Era
UroToday.com - In the online edition of the Journal of Clinical Oncology, a multi-institutional study reports on prostate cancer (CaP)-specific mortality after radical prostatectomy (RP) treated since the introduction of PSA. The study sought to establish a predictive nomogram and modeled the nomogram on 6,398 patients treated with RP at Baylor and MSKCC between 1987 and 2005.
Categories: Men's Health News
Racial Differences In Trust And Regular Source Of Patient Care And The Implications For Prostate Cancer Screening Use
UroToday.com - An article in the online edition of Cancer assesses differences in prostate cancer (CaP) treatment, trust and regular patient care based upon patient race. The North Carolina-Louisiana prostate Cancer Project (PCaP) is a population-based study of men identified shortly after CaP diagnosis. Enrollment began in 2004, however there was a temporary study enrollment lapse in Louisiana due to Hurricane Katrina.
Categories: Men's Health News
Male Hormone May Trigger Gene Fusion That Leads To Prostate Cancer, Study
Researchers in the US have discovered that the male hormone androgen may trigger the gene fusion that leads to the development of prostate cancer: they found that pieces of chromosome that normally sit far apart, relocate near each other after exposure to androgen, and this sets the scene for the genes to fuse.
Categories: Men's Health News
New Study Reviews Science Behind Efficacy Of Biofield Therapies - Reiki, Therapeutic Touch And Healing Touch
Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve. However, longer-term effects are less clear. Dr. Shamini Jain, from the UCLA Division of Cancer Prevention and Control Research, and Dr.
Categories: Men's Health News
Major Cancer Meeting Highlights Practice-Changing Cancer Studies
4 news briefings with live webcast previewing studies The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting. News briefing 1 When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern) What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Categories: Men's Health News
Study Uncovers Key To How 'Triggering Event' In Cancer Occurs
Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop. The study found that pieces of chromosome relocate near each other after exposure to the hormone androgen. This sets the scene for the gene fusion to occur. The finding is reported online Oct. 29 in Science Express.
Categories: Men's Health News
